prostaglandin Bx
phospholipase A2 inhibitor; polymeric derivative of diketo-PGB1; mean MW 2,200
Also Known As:
PGBx; poly 15-keto-PGB1; poly 15-ketoprostaglandin B1; polymeric 15-keto-PGB1; Prostaglandin Bx
Networked: 14
relevant articles (3 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Obesity
01/01/1982
- " PGBx, a polymeric prostaglandin, in chronic doses therapeutic for hereditary diabetes and hereditary obesity in mice, produces significant increases of blood neutrophils and lymphocytes in normal mice, hereditary diabetic mice, and hereditary obese mice. " 01/01/1980
- " This suggests that PGBx effects on obesity and appetite are not mediated through a blood glucose mechanism." 01/01/1980
- " Dose-dependent reduction of hereditary obesity in the non-diabetic mouse by polymeric prostaglandin PGBx." 01/01/1979
- " A polymeric derivative of prostaglandin B1, PGBX, which reactivates phosphorylation in damaged mitochondria, is shown to normalize the high blood glucose, obesity, and excessive appetite of the hereditary diabetic mouse. "
|
2. | Wounds and Injuries (Trauma)
|
3. | Myocardial Infarction
|
4. | Ischemia
|
5. | Brain Ischemia (Cerebral Ischemia)
|
|
Related Drugs and Biologics
Related Therapies and Procedures